subject: UMLS:C5238974

object_name: ovarian cancer


subject: UMLS:C5238974

object_name: ovarian neoplasm

tested_intervention: yes


subject: UMLS:C5238974

object_name: ovarian carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Shoulder lesion, unspecified

tested_intervention: unsure


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Umbilical hernia without mention of obstruction or gangrene


subject: CHEBI:3215

object_name: Umbilical hernia


subject: UMLS:C0308803

subject_name: dexamethasone injection

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C0308803

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: UNII:1351PE5UGS

subject_name: Elotuzumab


subject: UNII:1351PE5UGS


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Cancer of Head


subject: CHEBI:31355

object_name: Throat cancer


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:167574

subject_name: Semaglutide

object_name: opiate dependence


subject: CHEBI:167574

object_name: psychosis


subject: CHEBI:167574

object_name: mental disorder


subject: CHEBI:167574

object_name: psychiatric disorder


subject: CHEBI:167574

object_name: Chemically-Induced Disorders


subject: CHEBI:167574

object_name: substance-related disorder


subject: CHEBI:167574

object_name: Narcotic-Related Disorders


subject: CHEBI:167574

object_name: Opioid Abuse and Addiction


subject: UNII:25CG88L0BB

subject_name: Brensocatib

object_name: cystic fibrosis


subject: CHEBI:4953

subject_name: Exemestane

object_name: lung cancer


subject: CHEBI:4953

object_name: lung neoplasm


subject: CHEBI:4953

object_name: lung carcinoma


subject: CHEBI:132082

subject_name: Entinostat

object_name: Childhood Breast Carcinoma


subject: CHEBI:132082

object_name: breast carcinoma


subject: CHEBI:132082

object_name: breast cancer


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: PUBCHEM.COMPOUND:148293990

object_name: Papulopustular Rosacea


subject: PUBCHEM.COMPOUND:148293990

object_name: seborrheic dermatitis


subject: DRUGBANK:DB19143


subject: DRUGBANK:DB19143


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: castration-resistant prostate carcinoma


subject: UNII:KZ3DLD11RQ

object_name: liver carcinoma


subject: UNII:2372V1TKXK

subject_name: Lanadelumab

object_name: hereditary periodic fever syndrome


subject: UMLS:C4044724


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: benign neoplasm


subject: UMLS:C0003442

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C0003442

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355

object_name: myeloproliferative neoplasm


subject: CHEBI:31355

object_name: leukemia


subject: CHEBI:31355

object_name: childhood leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: UMLS:C5853307

object_name: choroideremia


subject: UNII:G786V328X6

subject_name: Zatolmilast

object_name: Alzheimer disease


subject: CHEBI:6801

subject_name: Metformin

object_name: cervical polyp


subject: CHEBI:6801

object_name: squamous cell carcinoma


subject: CHEBI:6801

object_name: adenosquamous carcinoma


subject: CHEBI:6801

object_name: esophageal adenocarcinoma


subject: CHEBI:6801

object_name: lung adenocarcinoma


subject: CHEBI:6801

object_name: cervical adenocarcinoma


subject: CHEBI:6801

object_name: adenocarcinoma


subject: CHEBI:6801

object_name: bile duct adenocarcinoma


subject: CHEBI:6801

object_name: gastric adenocarcinoma


subject: CHEBI:167309

subject_name: Methadone

object_name: Neonatal Opiate Withdrawal Syndrome


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C5206860

subject_name: Rusfertide

object_name: hemochromatosis


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:5281767

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:5281767

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:5281767

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:46245

subject_name: Ubidecarenone


subject: CHEBI:46245


subject: CHEBI:46245


subject: CHEBI:46245


subject: RXCUI:1799212

subject_name: sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet

object_name: hepatitis C


subject: UMLS:C0042210

subject_name: Vaccines

object_name: human papilloma virus infection


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: acute coronary syndrome


subject: CHEBI:28939

object_name: Angina pectoris


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: coronary artery disorder


subject: UMLS:C3714803

object_name: coronary atherosclerosis


subject: UMLS:C3714803

object_name: contrast-induced nephropathy


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:28939

object_name: psychosis


subject: CHEBI:28939

object_name: Nonorganic psychosis


subject: CHEBI:28939

object_name: Psychosis, CTCAE


subject: PUBCHEM.COMPOUND:44602504

subject_name: Etrasimod

object_name: Crohn disease


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Childhood Breast Carcinoma


subject: CHEBI:8869

object_name: breast carcinoma


subject: CHEBI:8869

object_name: breast cancer


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Neonatal encephalopathy


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:46245

object_name: end stage renal failure


subject: CHEBI:46245

object_name: Chronic uremia


subject: GTOPDB:8944

subject_name: emactuzumab

object_name: Recurrent Primary Peritoneal Carcinoma


subject: GTOPDB:8944

object_name: primary peritoneal serous adenocarcinoma


subject: GTOPDB:8944

object_name: peritoneal serous adenocarcinoma


subject: GTOPDB:8944

object_name: fallopian tube adenocarcinoma


subject: GTOPDB:8944

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: GTOPDB:8944

object_name: Recurrent Fallopian Tube Carcinoma


subject: GTOPDB:8944

object_name: fallopian tube transitional cell carcinoma


subject: GTOPDB:8944

object_name: Recurrent ovarian cancer


subject: GTOPDB:8944

object_name: fallopian tube clear cell adenocarcinoma


subject: GTOPDB:8944

object_name: fallopian tube serous adenocarcinoma


subject: GTOPDB:8944

object_name: malignant ovarian Brenner tumor


subject: GTOPDB:8944

object_name: fallopian tube mucinous adenocarcinoma


subject: GTOPDB:8944

object_name: fallopian tube endometrioid adenocarcinoma


subject: GTOPDB:8944

object_name: ovarian transitional cell carcinoma


subject: GTOPDB:8944

object_name: undifferentiated ovarian carcinoma


subject: GTOPDB:8944

object_name: ovarian clear cell adenocarcinoma


subject: GTOPDB:8944

object_name: ovarian adenocarcinoma


subject: GTOPDB:8944

object_name: ovarian endometrioid adenocarcinoma


subject: GTOPDB:8944

object_name: ovarian serous adenocarcinoma


subject: GTOPDB:8944

object_name: ovarian seromucinous carcinoma


subject: GTOPDB:8944

object_name: Primary mucinous adenocarcinoma of ovary


subject: GTOPDB:8944

object_name: ovarian mucinous adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:6FY6EI1X8R

object_name: primary peritoneal serous adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: peritoneal serous adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: fallopian tube adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: UNII:6FY6EI1X8R

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:6FY6EI1X8R

object_name: fallopian tube transitional cell carcinoma


subject: UNII:6FY6EI1X8R

object_name: Recurrent ovarian cancer


subject: UNII:6FY6EI1X8R

object_name: fallopian tube clear cell adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: fallopian tube serous adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: malignant ovarian Brenner tumor


subject: UNII:6FY6EI1X8R

object_name: fallopian tube mucinous adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: fallopian tube endometrioid adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: ovarian transitional cell carcinoma


subject: UNII:6FY6EI1X8R

object_name: undifferentiated ovarian carcinoma


subject: UNII:6FY6EI1X8R

object_name: ovarian clear cell adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: ovarian adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: ovarian endometrioid adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: ovarian serous adenocarcinoma


subject: UNII:6FY6EI1X8R

object_name: ovarian seromucinous carcinoma


subject: UNII:6FY6EI1X8R

object_name: Primary mucinous adenocarcinoma of ovary


subject: UNII:6FY6EI1X8R

object_name: ovarian mucinous adenocarcinoma


subject: UMLS:C4078926

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C4078926

object_name: primary peritoneal serous adenocarcinoma


subject: UMLS:C4078926

object_name: peritoneal serous adenocarcinoma


subject: UMLS:C4078926

object_name: fallopian tube adenocarcinoma


subject: UMLS:C4078926

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: UMLS:C4078926

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C4078926

object_name: fallopian tube transitional cell carcinoma


subject: UMLS:C4078926

object_name: Recurrent ovarian cancer


subject: UMLS:C4078926

object_name: fallopian tube clear cell adenocarcinoma


subject: UMLS:C4078926

object_name: fallopian tube serous adenocarcinoma


subject: UMLS:C4078926

object_name: malignant ovarian Brenner tumor


subject: UMLS:C4078926

object_name: fallopian tube mucinous adenocarcinoma


subject: UMLS:C4078926

object_name: fallopian tube endometrioid adenocarcinoma


subject: UMLS:C4078926

object_name: ovarian transitional cell carcinoma


subject: UMLS:C4078926

object_name: undifferentiated ovarian carcinoma


subject: UMLS:C4078926

object_name: ovarian clear cell adenocarcinoma


subject: UMLS:C4078926

object_name: ovarian adenocarcinoma


subject: UMLS:C4078926

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C4078926

object_name: ovarian serous adenocarcinoma


subject: UMLS:C4078926

object_name: ovarian seromucinous carcinoma


subject: UMLS:C4078926

object_name: Primary mucinous adenocarcinoma of ovary


subject: UMLS:C4078926

object_name: ovarian mucinous adenocarcinoma


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: type 2 diabetes mellitus


subject: UMLS:C0149473

subject_name: Zoladex

object_name: prostate carcinoma


subject: UMLS:C0149473

object_name: prostate cancer


subject: UMLS:C3272416

subject_name: PSMA-targeted Docetaxel Nanoparticles BIND-014

object_name: cervical cancer


subject: UMLS:C3272416

object_name: cervical carcinoma


subject: UMLS:C3272416

object_name: cholangiocarcinoma


subject: UMLS:C3272416

object_name: urothelial carcinoma


subject: UMLS:C3272416

object_name: transitional cell carcinoma


subject: UMLS:C3272416

object_name: head and neck squamous cell carcinoma


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: gastric adenocarcinoma


subject: UNII:P0GVQ9A4S5


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:23359

subject_name: colchicine

object_name: Graft failure


subject: UNII:Y6M3205516

subject_name: lumretuzumab

object_name: Childhood Breast Carcinoma


subject: UNII:Y6M3205516

object_name: breast carcinoma


subject: UNII:Y6M3205516

object_name: breast cancer


subject: UMLS:C3641720


subject: UMLS:C3641720


subject: UMLS:C3641720


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Neck pain


subject: PUBCHEM.COMPOUND:521372

object_name: Neck Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:521372

object_name: Neck Pain, CTCAE 3.0


subject: UMLS:C4724858

object_name: Solid Neoplasm


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Abdominal Infection


subject: CHEBI:67357

subject_name: Dolastatin 10

object_name: prostate carcinoma


subject: CHEBI:67357

object_name: prostate cancer


subject: UMLS:C0082338

subject_name: dolastatin 10


subject: UMLS:C0082338


subject: CHEBI:58097

object_name: liver neoplasm


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: stroke disorder


subject: CHEBI:94518

object_name: cerebrovascular disorder


subject: CHEBI:94518

object_name: Stroke (heart beat)


subject: CHEBI:94518

object_name: Stroke, CTCAE


subject: CHEBI:94518

object_name: intracerebral hemorrhage


subject: CHEBI:15379

subject_name: Oxygen

object_name: Burn injury


subject: UMLS:C2700355

subject_name: Kalinox 170 Bar


subject: UNII:MJ4PTD2VVW

subject_name: GALANTAMINE HYDROBROMIDE

object_name: Presenile dementia


subject: UNII:MJ4PTD2VVW

object_name: dementia


subject: UNII:MJ4PTD2VVW

object_name: brain disorder


subject: UNII:MJ4PTD2VVW

object_name: mental disorder


subject: UNII:MJ4PTD2VVW

object_name: psychiatric disorder


subject: CHEBI:42944

subject_name: Galantamine


subject: CHEBI:42944


subject: CHEBI:42944


subject: CHEBI:42944


subject: CHEBI:42944


subject: CHEBI:174615

object_name: Regional Neuroblastoma


subject: CHEBI:174615

object_name: Localized Resectable Neuroblastoma


subject: CHEBI:174615

object_name: Localized Unresectable Neuroblastoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: Disseminated neuroblastoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Stage 4S neuroblastoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Childhood Ganglioneuroblastoma


subject: PUBCHEM.COMPOUND:16760419

object_name: ganglioneuroblastoma


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: GTOPDB:12990

subject_name: sintilimab

object_name: esophageal squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Anorexia


subject: CHEBI:167574

subject_name: Semaglutide

object_name: alcohol abuse


subject: CHEBI:167574

object_name: alcohol dependence


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Vocal cord cyst


subject: CHEBI:3215

object_name: polyp of vocal cord


subject: CHEBI:3215

object_name: Disorder of vocal cord


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: CHEBI:64030

subject_name: tetrabenazine

object_name: Huntington disease


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: orthopedic disorders of spine


subject: MESH:C000722725

subject_name: PRIME-2-CoV_Beta COVID-19 vaccine


subject: CHEBI:6456

subject_name: Lidocaine

object_name: adolescent idiopathic scoliosis


subject: CHEBI:6456

object_name: scoliosis, isolated, susceptibility to, 1


subject: UMLS:C3540798

subject_name: Food allergenic extracts

object_name: type 2 diabetes mellitus


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: treatment resistant depression


subject: CHEBI:3160


subject: CHEBI:3160

object_name: major depressive disorder


subject: CHEBI:3160

object_name: major depressive episode


subject: CHEBI:3160

object_name: endogenous depression


subject: CHEBI:8364

subject_name: Prazosin

object_name: post-traumatic stress disorder


subject: UMLS:C2344255

subject_name: BD Alcohol

object_name: Androgen excess


subject: CHEBI:52683

subject_name: Butylene glycol


subject: UMLS:C4724025

subject_name: babaodan capsule


subject: UMLS:C5551437

subject_name: babao dan


subject: CHEBI:81851

subject_name: Calcium formate

object_name: rectal neoplasm


subject: CHEBI:15740

subject_name: formate


subject: CHEBI:30751

subject_name: Formic acid


subject: UMLS:C0220832


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: cellulitis


subject: CHEBI:3770

object_name: cellulitis on exam (physical finding)


subject: UMLS:C0041044


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: malignant glioma


subject: UMLS:C3896806


subject: HMDB:HMDB0015666

subject_name: Lornoxicam

object_name: Alzheimer disease


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: liver carcinoma


subject: UMLS:C5706371

subject_name: mRNA-encoded Anti-CD3/Anti-CLDN6 Bispecific Antibody BNT142

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706371

object_name: Adult Solid Neoplasm


subject: UMLS:C5706371

object_name: Solid Neoplasm


subject: MESH:D010919

subject_name: Placebos

object_name: attention deficit hyperactivity disorder, inattentive type


subject: MESH:D010919


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: Hodgkin Disease


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Arthralgia


subject: CHEBI:84094

object_name: Arthralgia, CTCAE


subject: CHEBI:84094

object_name: Musculoskeletal Complication


subject: CHEBI:84094

object_name: sexual disorder


subject: CHEBI:84094

object_name: physiological sexual disorder


subject: CHEBI:84094

object_name: Childhood Breast Carcinoma


subject: CHEBI:84094

object_name: breast carcinoma


subject: CHEBI:84094

object_name: breast cancer


subject: CHEBI:84094

object_name: Hot Flashes, CTCAE


subject: CHEBI:84094

object_name: Hot flashes


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: UNII:97IQ273H4L

subject_name: Fostemsavir

object_name: HIV-1 infection


subject: UMLS:C0379896

subject_name: Detralex

object_name: hemorrhoid


subject: UMLS:C0379896

object_name: Hemorrhoids, CTCAE 3.0


subject: UMLS:C0379896

object_name: Hemorrhoids, CTCAE 5.0


subject: CHEBI:23965

subject_name: estradiol

object_name: vulvodynia


subject: CHEBI:23965

object_name: vulvar lichen sclerosus


subject: CHEBI:232102

object_name: Immunization reaction


subject: PUBCHEM.COMPOUND:5464076


subject: CHEBI:53329


subject: CHEBI:34574

object_name: chronic kidney disease


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: traumatic encephalopathy


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: Acute Ischemic Stroke


subject: UNII:19FUJ2C58T

object_name: Ischemic stroke


subject: UMLS:C0022585

subject_name: Keratolytic Agents

object_name: tinea unguium


subject: UMLS:C1442872

subject_name: Antifungal brand of miconazole nitrate


subject: UMLS:C0003308

subject_name: Antifungal Agents


subject: UMLS:C5399711

subject_name: Antifungal [APC]


subject: UMLS:C0305062

subject_name: Tetanus Toxoid

object_name: Pregnant


subject: GTOPDB:11180

subject_name: apitegromab

object_name: Muscle Atrophy


subject: GTOPDB:11180

object_name: spinal muscular atrophy


subject: GTOPDB:11180

object_name: proximal spinal muscular atrophy


subject: GTOPDB:11180

object_name: Atrophic


subject: GTOPDB:11180

object_name: spinal muscular atrophy, type II


subject: GTOPDB:11180

object_name: spinal muscular atrophy, type III


subject: GTOPDB:11180

object_name: neuromuscular disease


subject: GTOPDB:11180

object_name: Neuromuscular Manifestations


subject: GTOPDB:11180

object_name: Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594326

subject_name: APITEGROMAB


subject: CHEMBL.COMPOUND:CHEMBL4594326


subject: CHEMBL.COMPOUND:CHEMBL4594326


subject: CHEMBL.COMPOUND:CHEMBL4594326


subject: CHEMBL.COMPOUND:CHEMBL4594326


subject: CHEMBL.COMPOUND:CHEMBL4594326


subject: CHEMBL.COMPOUND:CHEMBL4594326


subject: CHEMBL.COMPOUND:CHEMBL4594326


subject: CHEMBL.COMPOUND:CHEMBL4594326


subject: UMLS:C5421022


subject: UMLS:C5421022


subject: UMLS:C5421022


subject: UMLS:C5421022


subject: UMLS:C5421022


subject: UMLS:C5421022


subject: UMLS:C5421022


subject: UMLS:C5421022


subject: UMLS:C5421022


subject: CHEBI:231679

subject_name: ipilimumab

object_name: nephroblastoma


subject: CHEBI:231679

object_name: Wilms tumor


subject: CHEBI:231679

object_name: childhood kidney Wilms tumor


subject: CHEBI:231679

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:231679

object_name: rhabdomyosarcoma


subject: CHEBI:231679

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:231679

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:231679

object_name: Ewing sarcoma


subject: CHEBI:231679

object_name: hepatoblastoma


subject: CHEBI:231679

object_name: Childhood Neuroblastoma


subject: CHEBI:231679

object_name: neuroblastoma


subject: CHEBI:231679

object_name: pediatric osteosarcoma


subject: CHEBI:231679

object_name: Osteosarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:Y64GQ0KC0A

subject_name: Teprotumumab

object_name: euthyroid Graves orbitopathy


subject: UNII:Y64GQ0KC0A

object_name: endocrine exophthalmos


subject: UMLS:C2346815


subject: UMLS:C2346815


subject: CHEBI:33853

subject_name: phenols

object_name: chronic pain (diagnosis)


subject: CHEBI:33853

object_name: Chronic pain


subject: CHEBI:33853

object_name: osteoarthritis, knee


subject: CHEBI:15882

subject_name: Phenol


subject: CHEBI:15882


subject: CHEBI:15882


subject: CHEBI:16164

subject_name: pyrogallol


subject: CHEBI:16164


subject: CHEBI:16164


subject: CHEBI:681569

subject_name: Clofarabine

object_name: peroxisomal disease


subject: CHEBI:681569

object_name: lysosomal storage disease


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UMLS:C1337396

subject_name: minocycline HCl microspheres

object_name: short rib dysplasia


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Spasticity as sequela of stroke


subject: PUBCHEM.COMPOUND:9891967

subject_name: Silodosin

object_name: nephrolithiasis


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:36791

object_name: COPD, severe early onset


subject: CHEBI:36791

object_name: chronic obstructive pulmonary disease


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: UMLS:C3827143

subject_name: Cetuximab-IRDye 800CW

object_name: rectal carcinoma


subject: UMLS:C3827143

object_name: rectal cancer


subject: UMLS:C3827143

object_name: Childhood Rectal Carcinoma


subject: CHEBI:9927

subject_name: Valsartan

object_name: kidney disorder


subject: CHEBI:9927

object_name: impaired renal function disease


subject: CHEBI:9927

object_name: HIV infection


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate

object_name: Uterine hemorrhage


subject: PUBCHEM.COMPOUND:541197

object_name: Metrorrhagia


subject: PUBCHEM.COMPOUND:541197

object_name: Break-through bleeding (finding)


subject: PUBCHEM.COMPOUND:541197

object_name: Uses contraception (finding)


subject: PUBCHEM.COMPOUND:541197

object_name: Traumatic implant


subject: CHEBI:7627

subject_name: Norethisterone


subject: CHEBI:7627


subject: CHEBI:7627


subject: CHEBI:7627


subject: CHEBI:7627


subject: CHEBI:44557

subject_name: Nitrilotriacetic acid


subject: CHEBI:44557


subject: CHEBI:44557


subject: CHEBI:44557


subject: CHEBI:44557


subject: CHEBI:39054

subject_name: NTA


subject: CHEBI:39054


subject: CHEBI:39054


subject: CHEBI:39054


subject: CHEBI:39054


subject: CHEBI:136034

subject_name: Afamelanotide

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:136034

object_name: vitiligo


subject: UMLS:C0066889

subject_name: MT-I


subject: UMLS:C0066889


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: type 1 diabetes mellitus


subject: CHEBI:167574

subject_name: Semaglutide


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: liver cancer


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: epilepsy


subject: CHEBI:6538

subject_name: Loratadine

object_name: childhood onset asthma


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021

object_name: liver neoplasm


subject: CHEBI:95021

object_name: Adult Liver Carcinoma


subject: CHEBI:95021

object_name: liver carcinoma


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:18220

subject_name: Isoflavone

object_name: type 2 diabetes mellitus


subject: CHEBI:18220

object_name: Diabetes


subject: CHEBI:18220

object_name: diabetes mellitus


subject: CHEBI:18220

object_name: Cardiovascular Risk


subject: UMLS:C0074926

subject_name: Soy Proteins


subject: UMLS:C0074926


subject: UMLS:C0074926


subject: UMLS:C0074926


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: mood (physical finding)


subject: CHEBI:26710

object_name: salt intake


subject: UMLS:C1550678

subject_name: Water Specimen


subject: UMLS:C1550678


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:8805

subject_name: Repaglinide

object_name: Plexosarcoma


subject: UMLS:C4521070

object_name: dyspepsia


subject: UMLS:C4521070

object_name: Nausea, CTCAE_5


subject: UMLS:C4521070

object_name: Nausea


subject: UMLS:C4521070

object_name: Nausea, CTCAE_3


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Paranoia


subject: PUBCHEM.COMPOUND:53477758

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:53477758

object_name: schizophrenia 18


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C3530191

object_name: cocaine use disorder


subject: UMLS:C5881942

subject_name: Ixchiq

object_name: chikungunya


subject: UMLS:C4087043

subject_name: lenzilumab

object_name: rheumatoid arthritis


subject: CHEBI:149509

object_name: Liver Fibrosis


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:8774

subject_name: Ramipril


subject: CHEBI:45409

subject_name: Ritonavir

object_name: liver failure


subject: CHEMBL.COMPOUND:CHEMBL183041

subject_name: Tipranavir


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: secondary hyperparathyroidism


subject: CHEBI:31186

object_name: chronic kidney disease


subject: CHEBI:31186

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:31186

object_name: vitamin D deficiency


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG


subject: UMLS:C1145201


subject: UMLS:C1145201


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: UMLS:C0876119

subject_name: Paxil CR

object_name: panic disorder


subject: UMLS:C0876119

object_name: panic disorder 1


subject: CHEBI:84739

object_name: Pulmonary disease caused by Mycobacteria


subject: CHEBI:2637

subject_name: Amikacin


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Control of hip fracture risk


subject: CHEBI:94518

object_name: hip fracture


subject: CHEBI:94518

object_name: anemia


subject: CHEBI:94518

object_name: Anemia, CTCAE


subject: GTOPDB:13611

subject_name: patisiran

object_name: amyloidosis


subject: UNII:50FKX8CB2Y

subject_name: Patisiran


subject: UMLS:C4329594

subject_name: CEA-MUC-1-TRICOM Vaccine CV301

object_name: non-small cell lung carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Thoracic Procedure Postoperative Complication


subject: CHEBI:41879

object_name: Postoperative Thoracic Procedure Complication, CTCAE


subject: CHEBI:41879

object_name: Dexamethasone adverse reaction


subject: CHEBI:8364

subject_name: Prazosin

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:132082

subject_name: Entinostat

object_name: colorectal cancer


subject: CHEBI:132082

object_name: colorectal carcinoma


subject: CHEBI:132082

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: preeclampsia postpartum


subject: CHEBI:38290

object_name: severe pre-eclampsia


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: PUBCHEM.COMPOUND:3367

object_name: psoriatic arthritis


subject: PUBCHEM.COMPOUND:3367

object_name: psoriasis


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:15940

subject_name: Niacin

object_name: psychosis


subject: CHEBI:15940

object_name: Nonorganic psychosis


subject: CHEBI:15940

object_name: Psychosis, CTCAE


subject: UMLS:C1134558

subject_name: Chinese Herbs

object_name: myofascial pain syndrome


subject: UMLS:C1134558

object_name: fibromyalgia


subject: CHEBI:4470

subject_name: Dextromethorphan

object_name: plasma cell myeloma


subject: CHEBI:73024

subject_name: O-acetylcarnitine


subject: UMLS:C0600146

subject_name: Alcar


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:6801

subject_name: Metformin

object_name: rectal carcinoma


subject: CHEBI:6801

object_name: rectal cancer


subject: CHEBI:6801

object_name: Childhood Rectal Carcinoma


subject: CHEBI:6801

object_name: metastatic malignant neoplasm in the lymph nodes


subject: CHEBI:6801

object_name: disease free survival


subject: CHEBI:6801

object_name: overall survival


subject: UMLS:C2347903

subject_name: Recombinant Adenovirus-Interferon SCH 721015

object_name: malignant pleural mesothelioma


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: periapical periodontitis


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:93826

subject_name: Benfluorex

object_name: type 2 diabetes mellitus


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: thyroid tumor


subject: UNII:2S9ZZM9Q9V

object_name: thyroid gland carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: thyroid cancer


subject: UNII:2S9ZZM9Q9V

object_name: carcinoma


subject: UMLS:C1957299

object_name: Urinary Urgency


subject: CHEBI:192614

subject_name: Homosildenafil


subject: CHEBI:192614

object_name: Diabetes


subject: CHEBI:192614

object_name: diabetes mellitus


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:131174

subject_name: Navitoclax

object_name: Mantle cell lymphoma refractory


subject: CHEBI:8884

subject_name: Rocuronium

object_name: no feeling or sensation of skin


subject: CHEBI:8884

object_name: Sensory Loss


subject: GTOPDB:13084

subject_name: narlumosbart

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5314993

subject_name: NARLUMOSBART


subject: UMLS:C5783725

subject_name: Narlumosbart


subject: CHEBI:50673

subject_name: Methimazole

object_name: hyperthyroidism


subject: CHEBI:50673

object_name: Hyperthyroidism, CTCAE


subject: CHEBI:55312

subject_name: diphenylmethane monoisocyanate


subject: CHEBI:55312


subject: PUBCHEM.COMPOUND:492132

subject_name: Semapimod

object_name: Crohn disease


subject: UMLS:C3537192

subject_name: Tumor Necrosis Factor Inhibitors

object_name: rheumatoid arthritis


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: pain agnosia


subject: CHEBI:17045

object_name: Pain insensitivity


subject: UMLS:C5907979

subject_name: Base Edited Natural Killer Cells NK510

object_name: Stomach cancer


subject: UMLS:C5907979

object_name: gastric cancer


subject: CHEBI:84040

object_name: coronary artery disorder


subject: CHEBI:84040

object_name: coronary atherosclerosis


subject: CHEBI:84040

object_name: type 2 diabetes mellitus


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: UMLS:C1101322

subject_name: trans-Resveratrol


subject: UMLS:C1101322


subject: UMLS:C1101322


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:28939

object_name: mitochondrial disease


subject: UMLS:C0003233

subject_name: Antibiotics, Aminoglycoside

object_name: kidney failure


subject: UMLS:C0003233

object_name: Renal dysfunction


subject: UMLS:C0003233

object_name: Infection


subject: UMLS:C0003233

object_name: infectious disease


subject: UMLS:C0003233

object_name: Adverse Event Associated with Infection


subject: CHEBI:47779

subject_name: aminoglycoside


subject: CHEBI:47779


subject: CHEBI:47779


subject: CHEBI:47779


subject: CHEBI:47779


subject: UMLS:C3536835

subject_name: Aminoglycoside [EPC]


subject: UMLS:C3536835


subject: UMLS:C3536835


subject: UMLS:C3536835


subject: UMLS:C3536835


subject: CHEBI:91398

subject_name: Tivantinib


subject: CHEBI:91398


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Adult idiopathic generalized osteoporosis


subject: CHEBI:60802

subject_name: ropivacaine

object_name: appendicitis


subject: CHEBI:60802

object_name: Appendicitis, CTCAE


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Headache


subject: CHEBI:8378

object_name: Headache, CTCAE


subject: UMLS:C2348769

subject_name: Therapeutic Hemin

object_name: variegate porphyria


subject: UMLS:C2348769

object_name: acute intermittent porphyria


subject: UMLS:C2348769

object_name: hereditary coproporphyria


subject: CHEBI:75929

object_name: chronic tic disorder


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:50634

object_name: type 1 diabetes mellitus


subject: CHEBI:27690

subject_name: Acetazolamide


subject: UMLS:C2825840

subject_name: Xermelo

object_name: carcinoid syndrome


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Restless legs


subject: UMLS:C5203993

subject_name: Antifungal PC945

object_name: asthma


subject: UMLS:C5203993

object_name: Respiratory aspergillosis


subject: UMLS:C5203993

object_name: Candidiasis of lung


subject: UMLS:C5203993

object_name: bronchiectasis


subject: UMLS:C5203993

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C5203993

object_name: COPD, severe early onset


subject: UMLS:C5203993

object_name: chronic obstructive pulmonary disease


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:4026

object_name: Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: diffuse large B-cell lymphoma


subject: UNII:AG9MHG098Z

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:AG9MHG098Z

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Adult Meningioma


subject: UNII:MRL3739G66

object_name: benign meningioma


subject: UNII:MRL3739G66

object_name: familial meningioma


subject: UNII:MRL3739G66

object_name: pediatric meningioma


subject: UNII:MRL3739G66

object_name: meningioma


subject: UNII:MRL3739G66

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: UNII:MRL3739G66

object_name: Refractory Primary Central Nervous System Neoplasm


subject: UNII:MRL3739G66

object_name: Recurrent Malignant Glioma


subject: UNII:MRL3739G66

object_name: Recurrent Medulloblastoma


subject: UNII:MRL3739G66

object_name: Recurrent Childhood Medulloblastoma


subject: UNII:MRL3739G66

object_name: High grade glioma


subject: UNII:MRL3739G66

object_name: malignant glioma


subject: UNII:MRL3739G66

object_name: Recurrent Diffuse Intrinsic Pontine Glioma


subject: UNII:MRL3739G66

object_name: Refractory Diffuse Intrinsic Pontine Glioma


subject: UNII:MRL3739G66

object_name: intracranial primitive neuroectodermal tumor


subject: UNII:MRL3739G66

object_name: embryonal neoplasm


subject: UNII:MRL3739G66

object_name: Refractory Malignant Glioma


subject: UNII:MRL3739G66

object_name: Refractory Medulloblastoma


subject: UNII:MRL3739G66

object_name: anaplastic ependymoma


subject: UNII:MRL3739G66

object_name: adult anaplastic ependymoma


subject: UNII:MRL3739G66

object_name: Childhood Anaplastic Ependymoma


subject: UNII:MRL3739G66

object_name: medulloblastoma


subject: UNII:MRL3739G66

object_name: childhood medulloblastoma


subject: UNII:MRL3739G66

object_name: adult medulloblastoma


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: Cardiac failure aggravated


subject: UMLS:C5417942

object_name: High Tumor Mutation Burden


subject: CHEBI:29105

subject_name: Velmanase alfa

object_name: Mannosidosis


subject: UMLS:C4521182

subject_name: Lamazym


subject: CHEBI:31355

subject_name: Carboplatin

object_name: childhood germ cell tumor


subject: CHEBI:31355

object_name: testicular germ cell tumor 1


subject: CHEBI:31355

object_name: childhood testicular germ cell tumor


subject: CHEBI:31355

object_name: extragonadal germ cell tumor


subject: CHEBI:31355

object_name: malignant soft tissue neoplasm


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026

object_name: liver cancer


subject: CHEBI:4026

object_name: liver neoplasm


subject: CHEBI:4026

object_name: Adult Liver Carcinoma


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911

object_name: liver carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: testicular germ cell tumor


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: ovarian cancer


subject: UNII:PVI5M0M1GW

object_name: ovarian neoplasm


subject: UNII:PVI5M0M1GW

object_name: ovarian carcinoma


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: colorectal neoplasm


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: UMLS:C4764272

subject_name: Botensilimab


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Tourette syndrome


subject: CHEBI:28939

object_name: tic disorder


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: localized primary osteoarthritis of both hips


subject: CHEBI:41879

object_name: osteoarthritis, hip


subject: CHEBI:50730

subject_name: Montelukast

object_name: peripheral vascular disease


subject: CHEBI:50730

object_name: peripheral arterial disease


subject: CHEBI:50730

object_name: atherosclerosis


subject: CHEBI:50730

object_name: Lower limb ischemia


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Advanced cancer


subject: CHEBI:233362

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:233362

object_name: Embolism, Tumor


subject: CHEBI:233362

object_name: Hormone receptor positive tumor


subject: CHEBI:233362

object_name: CCNE1 Gene Amplification


subject: CHEBI:91951

object_name: Childhood Solid Neoplasm


subject: CHEBI:91951

object_name: Adult Solid Neoplasm


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: UMLS:C5854463

subject_name: CDK2 Inhibitor INX-315

object_name: ovarian cancer


subject: UMLS:C5854463

object_name: ovarian neoplasm


subject: UMLS:C5854463

object_name: ovarian carcinoma


subject: UMLS:C5854463

object_name: Childhood Breast Carcinoma


subject: UMLS:C5854463

object_name: breast carcinoma


subject: UMLS:C5854463

object_name: breast cancer


subject: UMLS:C5854463


subject: UMLS:C5854463


subject: UMLS:C5854463

object_name: Solid Neoplasm


subject: UMLS:C5854463


subject: UMLS:C5854463


subject: UMLS:C5854463


subject: UMLS:C5854463

object_name: Neoplasm Metastasis


subject: UMLS:C5854463


subject: UMLS:C5854463

object_name: Carcinoma breast stage IV


subject: UMLS:C5854463

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5854463


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ

object_name: Advanced cancer


subject: UNII:2QD8YT8RWZ

object_name: Disseminated Malignant Neoplasm


subject: UNII:2QD8YT8RWZ

object_name: Embolism, Tumor


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ

object_name: Hormone receptor positive tumor


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ


subject: UNII:2QD8YT8RWZ

object_name: CCNE1 Gene Amplification


subject: CHEBI:4875

subject_name: Etanercept

object_name: pemphigus vulgaris


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Primary hypercholesterolemia


subject: CHEBI:50386

subject_name: cysteamine bitartrate

object_name: asthma


subject: CHEBI:17141

subject_name: Cysteamine


subject: UMLS:C0677666

subject_name: soy protein isolate

object_name: sarcopenia


subject: UMLS:C1883555

subject_name: Whey Protein Isolate


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Chronic low back pain


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: breast cancer


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:145374

subject_name: Enasidenib

object_name: Myelodysplasia


subject: CHEBI:145374

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:145374

object_name: childhood myelodysplastic syndrome


subject: CHEBI:145374

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Localized Prostate Carcinoma


subject: UNII:4T36H88UA7

object_name: Stage I Prostate Cancer AJCC v8


subject: UNII:4T36H88UA7

object_name: Stage II Prostate Cancer AJCC v8


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: previously untreated childhood rhabdomyosarcoma


subject: CHEBI:4026

object_name: Childhood Embryonal Rhabdomyosarcoma


subject: CHEBI:4026

object_name: childhood botryoid rhabdomyosarcoma


subject: CHEBI:4026

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:4026

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:4026

object_name: stage II adult soft tissue sarcoma


subject: CHEBI:4026

object_name: stage I adult soft tissue sarcoma


subject: CHEBI:4026

object_name: Stage I Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:4026

object_name: nonmetastatic childhood soft tissue sarcoma


subject: CHEBI:4026

object_name: childhood malignant mesenchymoma


subject: CHEBI:4026

object_name: adult malignant mesenchymoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:125400

subject_name: actinomycin D

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:125400


subject: CHEBI:125400

object_name: alveolar rhabdomyosarcoma


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:73678

object_name: Chalazion left eye, unspecified eyelid


subject: CHEBI:73678

object_name: Chalazion right eye, unspecified eyelid


subject: CHEBI:73678

object_name: Chalazion unspecified eye, unspecified eyelid


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:28864


subject: CHEBI:28864


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Allergic condition


subject: CHEBI:91594

object_name: small cell lung carcinoma


subject: UMLS:C0678133

subject_name: Taxol


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: atopic eczema


subject: CHEBI:94559

object_name: Pruritus, CTCAE


subject: CHEBI:94559

object_name: Pruritus


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: adult lymphoma


subject: UMLS:C0919079

object_name: lymphoma


subject: UMLS:C0919079

object_name: pediatric lymphoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: DRUGBANK:DB04981

object_name: prostate carcinoma


subject: DRUGBANK:DB04981

object_name: prostate cancer


subject: CHEBI:144094

subject_name: bicalutamide


subject: UNII:TC549UFL8P

object_name: ulcerative colitis


subject: UNII:TC549UFL8P

object_name: inflammatory bowel disease 1


subject: UMLS:C1831848


subject: UMLS:C1831848


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:6129

object_name: Back pain


subject: CHEBI:6129

object_name: Back Pain, CTCAE 3.0


subject: UNII:6NV440YIO0

subject_name: Simufilam

object_name: liver failure


subject: UMLS:C0667595

object_name: Crohn disease


subject: UNII:3JL137394Y

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:3JL137394Y

object_name: obesity


subject: UNII:3JL137394Y

object_name: Obesity, CTCAE


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid

object_name: osteoporosis


subject: CHEBI:37084

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:37084

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:37084

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:137359

object_name: sarcopenia


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: IgA Nephropathy


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: Mycoses


subject: PUBCHEM.COMPOUND:122173807

object_name: hepatobiliary disorder


subject: PUBCHEM.COMPOUND:122173807

object_name: liver disorder


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C2985186

object_name: diabetic kidney disease


subject: UMLS:C2985186

object_name: type 2 diabetes mellitus


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Dysentery, Shigella sonnei


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C3827163

subject_name: Cusatuzumab

object_name: cancer


subject: UMLS:C3827163

object_name: neoplasm


subject: CHEBI:37084

object_name: digestive system cancer


subject: CHEBI:37084

object_name: lung cancer


subject: CHEBI:37084

object_name: malnutrition


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Parkinson disease


subject: UNII:PE952ANF83

subject_name: Uproleselan

object_name: acute myeloid leukemia by FAB classification


subject: UNII:PE952ANF83

object_name: acute myeloid leukemia


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Childhood Neuroblastoma


subject: CHEBI:60802

object_name: neuroblastoma


subject: UNII:WZ9TJ0L9Y8

subject_name: Tinengotinib

object_name: cholangiocarcinoma


subject: UMLS:C5203356

subject_name: Tocilizumab Liquid Injection


subject: UMLS:C2959259

subject_name: Injection, tocilizumab, 1 mg administered


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Refractory Acute Biphenotypic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Refractory T-Cell Prolymphocytic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent T-Cell Prolymphocytic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: acute biphenotypic leukemia in relapse


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:Y8KTZ6Y35U

subject_name: PEGCRISANTASPASE

object_name: Refractory acute myeloid leukemia


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U


subject: UMLS:C3640058

subject_name: Asparec


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: PUBCHEM.COMPOUND:136170999

subject_name: FOLFIRI regimen

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:136170999

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:136170999

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:61397

subject_name: Neratinib

object_name: metastatic colorectal cancer


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:151315

subject_name: Heparin

object_name: familial lipoprotein lipase deficiency


subject: KEGG.COMPOUND:C00374


subject: UNII:F3HG38I0T1

subject_name: IMVOTAMAB

object_name: acquired idiopathic inflammatory myopathy


subject: UNII:F3HG38I0T1

object_name: idiopathic inflammatory myopathy


subject: UNII:F3HG38I0T1

object_name: myositis


subject: UMLS:C5236954

subject_name: Imvotamab


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: CD19 Positive


subject: CHEBI:4026

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:4026

object_name: Philadelphia Chromosome Positive


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: precursor B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:5281767

object_name: Advanced breast cancer


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:232328

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:232328

object_name: Recurrent Diffuse Intrinsic Pontine Glioma


subject: CHEBI:232328

object_name: Recurrent Diffuse Midline Glioma, H3 K27M-Mutant


subject: CHEBI:232328

object_name: grade III glioma


subject: CHEBI:232328

object_name: Recurrent WHO Grade 3 Glioma


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UNII:P5DKZ70636

subject_name: Paxalisib


subject: UNII:P5DKZ70636


subject: UNII:P5DKZ70636


subject: UNII:P5DKZ70636


subject: UNII:P5DKZ70636


subject: UNII:P5DKZ70636


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: castration-resistant prostate carcinoma


subject: UMLS:C4287690

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C4287690

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UMLS:C4287690

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C4287690

object_name: Adenocarcinoma of the prostate metastatic


subject: UMLS:C4287690

object_name: Metastatic Prostate Small Cell Neuroendocrine Carcinoma


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:68534


subject: CHEBI:68534


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:8024

subject_name: Perindopril

object_name: Adherence To Medication Regime


subject: CHEBI:5893

subject_name: Indapamide


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor

object_name: bipolar disorder


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C1579361

subject_name: Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)


subject: UMLS:C3537046

subject_name: Norepinephrine Reuptake Inhibitor [EPC]


subject: UMLS:C3537213

subject_name: Serotonin and Norepinephrine Reuptake Inhibitor [EPC]


subject: CHEBI:231683

subject_name: Anakinra

object_name: plasma cell myeloma


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:80165

object_name: cystic fibrosis


subject: CHEBI:80165

object_name: exocrine pancreatic insufficiency


subject: CHEBI:80270


subject: CHEBI:80270


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: UMLS:C1134696

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C1134696

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C1134696

object_name: Renal cell carcinoma recurrent


subject: UMLS:C1134696

object_name: Renal cancer recurrent


subject: UMLS:C1134696

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage III renal cell cancer


subject: UMLS:C1134696

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C1134696

object_name: Anal cancer stage IV


subject: UMLS:C1134696

object_name: Stage IV Anal Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Anal cancer recurrent


subject: UMLS:C1134696

object_name: Stage IIIA Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Stage IIIA Anal Cancer AJCC v8


subject: UMLS:C1134696

object_name: stage IIIA anal cancer


subject: UMLS:C1134696

object_name: Stage IIIB Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: stage IIIB anal cancer


subject: UMLS:C1134696

object_name: Stage IIIB Anal Cancer AJCC v8


subject: UMLS:C1134696

object_name: stage III vaginal cancer


subject: UMLS:C1134696

object_name: Stage III Vaginal Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Vaginal cancer recurrent


subject: UMLS:C1134696

object_name: stage IVA vaginal cancer


subject: UMLS:C1134696

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: UMLS:C1134696

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: UMLS:C1134696

object_name: Recurrent Rectal Cancer


subject: UMLS:C1134696

object_name: Distal Urethral Carcinoma


subject: UMLS:C1134696

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C1134696

object_name: Rectal cancer stage IV


subject: UMLS:C1134696

object_name: Stage IV Rectal Cancer AJCC v6


subject: UMLS:C1134696

object_name: posterior urethra cancer


subject: UMLS:C1134696

object_name: Proximal Urethral Carcinoma


subject: UMLS:C1134696

object_name: Stage III Rectal Cancer AJCC v6


subject: UMLS:C1134696

object_name: Stage III Rectal Cancer AJCC v7


subject: UMLS:C1134696

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C1134696

object_name: stage III cervical cancer


subject: UMLS:C1134696

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Cervical carcinoma stage IVA


subject: UMLS:C1134696

object_name: Cervical carcinoma stage IVB


subject: UMLS:C1134696

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C1134696

object_name: Recurrent Urethral Cancer


subject: UMLS:C1134696

object_name: Cervix carcinoma recurrent


subject: UMLS:C1134696

object_name: advanced adult primary liver cancer


subject: UMLS:C1134696

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UMLS:C1134696

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UMLS:C1134696

object_name: stage IV esophageal cancer


subject: UMLS:C1134696

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C1134696

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Ovarian cancer stage IV


subject: UMLS:C1134696

object_name: fallopian tube carcinoma


subject: UMLS:C1134696

object_name: fallopian tube cancer


subject: UMLS:C1134696

object_name: Stage III Esophageal Cancer AJCC v7


subject: UMLS:C1134696

object_name: Stage III Esophageal Cancer


subject: UMLS:C1134696

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C1134696

object_name: Ovarian cancer stage III


subject: UMLS:C1134696

object_name: Recurrent ovarian cancer


subject: UMLS:C1134696

object_name: urethral carcinoma associated with invasive bladder cancer


subject: UMLS:C1134696

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C1134696

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C1134696

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C1134696

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage III Prostate Cancer AJCC v7


subject: UMLS:C1134696

object_name: Carcinoma of the prostate stage III


subject: UMLS:C1134696

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C1134696

object_name: Prostate cancer recurrent


subject: UMLS:C1134696

object_name: Occult Lung Non-Small Cell Carcinoma


subject: UMLS:C1134696

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UMLS:C1134696

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1134696

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C1134696

object_name: male breast carcinoma


subject: UMLS:C1134696

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C1134696

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C1134696

object_name: Small intestine carcinoma recurrent


subject: UMLS:C1134696

object_name: PPoma


subject: UMLS:C1134696

object_name: Testis cancer recurrent


subject: UMLS:C1134696

object_name: stage III testicular cancer


subject: UMLS:C1134696

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: stage IV pancreatic cancer


subject: UMLS:C1134696

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1134696

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C1134696

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1134696

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C1134696

object_name: Pancreatic carcinoma stage III


subject: UMLS:C1134696

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C1134696

object_name: peritoneum cancer


subject: UMLS:C1134696

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C1134696

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IV Bladder Cancer AJCC v7


subject: UMLS:C1134696

object_name: Bladder cancer stage IV


subject: UMLS:C1134696

object_name: Stage IV Bladder Cancer AJCC v6


subject: UMLS:C1134696

object_name: Endometrial cancer stage III


subject: UMLS:C1134696

object_name: Recurrent Endometrial Cancer


subject: UMLS:C1134696

object_name: Bladder cancer recurrent


subject: UMLS:C1134696

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C1134696

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UMLS:C1134696

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1134696

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1134696

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C1134696

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C1134696

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UMLS:C1134696

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1134696

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C1134696

object_name: Laryngeal squamous cell carcinoma stage III


subject: UMLS:C1134696

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1134696

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C1134696

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1134696

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C1134696

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C1134696

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C1134696

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UMLS:C1134696

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UMLS:C1134696

object_name: metastatic gastrointestinal carcinoid tumor


subject: UMLS:C1134696

object_name: Colon cancer recurrent


subject: UMLS:C1134696

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C1134696

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage III Colon Cancer


subject: UMLS:C1134696

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Carcinoma breast stage IV


subject: UMLS:C1134696

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1134696

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1134696

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C1134696

object_name: Malignant neoplasm of gallbladder recurrent


subject: UMLS:C1134696

object_name: Vulval cancer metastatic


subject: UMLS:C1134696

object_name: Stage IVB Vulvar Cancer AJCC v6 and v7


subject: UMLS:C1134696

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: UMLS:C1134696

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C1134696

object_name: Stage III Vulvar Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage III Vulvar Cancer AJCC v7


subject: UMLS:C1134696

object_name: Vulval cancer stage III


subject: UMLS:C1134696

object_name: Stage III Vulvar Cancer AJCC v6


subject: UMLS:C1134696

object_name: Breast cancer recurrent


subject: UMLS:C1134696

object_name: Recurrent Vulvar Carcinoma


subject: UMLS:C1134696

object_name: Salivary gland cancer stage IV


subject: UMLS:C1134696

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1134696

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UMLS:C1134696

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C1134696

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C1134696

object_name: Salivary gland cancer stage III


subject: UMLS:C1134696

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1134696

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UMLS:C1134696

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UMLS:C1134696

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UMLS:C1134696

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UMLS:C1134696

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UMLS:C1134696

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: UMLS:C1134696

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UMLS:C1134696

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UMLS:C1134696

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: UMLS:C1134696

object_name: stage III papillary thyroid cancer


subject: UMLS:C1134696

object_name: Malignant neoplasm of stomach stage III


subject: UMLS:C1134696

object_name: recurrent gastric cancer


subject: UMLS:C1134696

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1134696

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1134696

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C1134696

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C1134696

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1134696

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1134696

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C1134696

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: UMLS:C1134696

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UMLS:C1134696

object_name: inflammatory breast carcinoma


subject: UMLS:C1134696

object_name: Recurrent Parathyroid Gland Carcinoma


subject: UMLS:C1134696

object_name: Metastatic Parathyroid Gland Carcinoma


subject: UMLS:C1134696

object_name: recurrent islet cell carcinoma


subject: UMLS:C1134696

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C1134696

object_name: newly diagnosed carcinoma of unknown primary


subject: UMLS:C1134696

object_name: lung carcinoid tumor


subject: UMLS:C1134696

object_name: Recurrent Carcinoma of Unknown Primary


subject: UMLS:C1134696

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C1134696

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C1134696

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UMLS:C1134696

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C1134696

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C1134696

object_name: Malignant pericardial effusion


subject: UMLS:C1134696

object_name: small intestine adenocarcinoma


subject: UMLS:C1134696

object_name: appendix carcinoma


subject: UMLS:C1134696

object_name: medullary thyroid gland carcinoma


subject: UMLS:C1134696

object_name: Malignant pleural effusion


subject: UMLS:C1134696

object_name: Secondary malignant neoplasm of skin


subject: UMLS:C1134696

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: UMLS:C1134696

object_name: pancreatic somatostatinoma


subject: UMLS:C1134696

object_name: somatostatinoma


subject: UMLS:C1134696

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C1134696

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C1134696

object_name: WDHA Syndrome


subject: UMLS:C1134696

object_name: VIPoma


subject: UMLS:C1134696

object_name: glucagonoma


subject: UMLS:C1134696

object_name: Zollinger-Ellison syndrome


subject: UMLS:C1134696

object_name: gastrinoma


subject: UMLS:C1134696

object_name: pancreatic gastrinoma


subject: UMLS:C1134696

object_name: insulinoma


subject: CHEBI:45863

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:45863

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:45863

object_name: Renal cell carcinoma recurrent


subject: CHEBI:45863

object_name: Renal cancer recurrent


subject: CHEBI:45863

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III renal cell cancer


subject: CHEBI:45863

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:45863

object_name: Anal cancer stage IV


subject: CHEBI:45863

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Anal cancer recurrent


subject: CHEBI:45863

object_name: Stage IIIA Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIIA Anal Cancer AJCC v8


subject: CHEBI:45863

object_name: stage IIIA anal cancer


subject: CHEBI:45863

object_name: Stage IIIB Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: stage IIIB anal cancer


subject: CHEBI:45863

object_name: Stage IIIB Anal Cancer AJCC v8


subject: CHEBI:45863

object_name: stage III vaginal cancer


subject: CHEBI:45863

object_name: Stage III Vaginal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Vaginal cancer recurrent


subject: CHEBI:45863

object_name: stage IVA vaginal cancer


subject: CHEBI:45863

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:45863

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:45863

object_name: Recurrent Rectal Cancer


subject: CHEBI:45863

object_name: Distal Urethral Carcinoma


subject: CHEBI:45863

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:45863

object_name: Rectal cancer stage IV


subject: CHEBI:45863

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:45863

object_name: posterior urethra cancer


subject: CHEBI:45863

object_name: Proximal Urethral Carcinoma


subject: CHEBI:45863

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:45863

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:45863

object_name: stage III cervical cancer


subject: CHEBI:45863

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Cervical carcinoma stage IVA


subject: CHEBI:45863

object_name: Cervical carcinoma stage IVB


subject: CHEBI:45863

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:45863

object_name: Recurrent Urethral Cancer


subject: CHEBI:45863

object_name: Cervix carcinoma recurrent


subject: CHEBI:45863

object_name: advanced adult primary liver cancer


subject: CHEBI:45863

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:45863

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:45863

object_name: stage IV esophageal cancer


subject: CHEBI:45863

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:45863

object_name: Stage III Esophageal Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage III Esophageal Cancer


subject: CHEBI:45863

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:45863

object_name: urethral carcinoma associated with invasive bladder cancer


subject: CHEBI:45863

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:45863

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:45863

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:45863

object_name: Carcinoma of the prostate stage III


subject: CHEBI:45863

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:45863

object_name: Prostate cancer recurrent


subject: CHEBI:45863

object_name: Occult Lung Non-Small Cell Carcinoma


subject: CHEBI:45863

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:45863

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:45863

object_name: Small intestine carcinoma recurrent


subject: CHEBI:45863

object_name: PPoma


subject: CHEBI:45863

object_name: Testis cancer recurrent


subject: CHEBI:45863

object_name: stage III testicular cancer


subject: CHEBI:45863

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:45863

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:45863

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:45863

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:45863

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:45863

object_name: Bladder cancer stage IV


subject: CHEBI:45863

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:45863

object_name: Endometrial cancer stage III


subject: CHEBI:45863

object_name: Bladder cancer recurrent


subject: CHEBI:45863

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:45863

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:45863

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:45863

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:45863

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:45863

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:45863

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:45863

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:45863

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:45863

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:45863

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:45863

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:45863

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:45863

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:45863

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:45863

object_name: Colon cancer recurrent


subject: CHEBI:45863

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Colon Cancer


subject: CHEBI:45863

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:45863

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:45863

object_name: Vulval cancer metastatic


subject: CHEBI:45863

object_name: Stage IVB Vulvar Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Vulvar Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Vulvar Cancer AJCC v7


subject: CHEBI:45863

object_name: Vulval cancer stage III


subject: CHEBI:45863

object_name: Stage III Vulvar Cancer AJCC v6


subject: CHEBI:45863

object_name: Recurrent Vulvar Carcinoma


subject: CHEBI:45863

object_name: Salivary gland cancer stage IV


subject: CHEBI:45863

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:45863

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:45863

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:45863

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:45863

object_name: Salivary gland cancer stage III


subject: CHEBI:45863

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:45863

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:45863

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:45863

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:45863

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:45863

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:45863

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:45863

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:45863

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:45863

object_name: stage III papillary thyroid cancer


subject: CHEBI:45863

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:45863

object_name: recurrent gastric cancer


subject: CHEBI:45863

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:45863

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:45863

object_name: inflammatory breast carcinoma


subject: CHEBI:45863

object_name: Recurrent Parathyroid Gland Carcinoma


subject: CHEBI:45863

object_name: Metastatic Parathyroid Gland Carcinoma


subject: CHEBI:45863

object_name: recurrent islet cell carcinoma


subject: CHEBI:45863

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:45863

object_name: newly diagnosed carcinoma of unknown primary


subject: CHEBI:45863

object_name: lung carcinoid tumor


subject: CHEBI:45863

object_name: Recurrent Carcinoma of Unknown Primary


subject: CHEBI:45863

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Recurrent Adrenal Cortical Carcinoma


subject: CHEBI:45863

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Malignant pericardial effusion


subject: CHEBI:45863

object_name: small intestine adenocarcinoma


subject: CHEBI:45863

object_name: appendix carcinoma


subject: CHEBI:45863

object_name: medullary thyroid gland carcinoma


subject: CHEBI:45863

object_name: Malignant pleural effusion


subject: CHEBI:45863

object_name: Secondary malignant neoplasm of skin


subject: CHEBI:45863

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: CHEBI:45863

object_name: pancreatic somatostatinoma


subject: CHEBI:45863

object_name: somatostatinoma


subject: CHEBI:45863

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:45863

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:45863

object_name: WDHA Syndrome


subject: CHEBI:45863

object_name: VIPoma


subject: CHEBI:45863

object_name: glucagonoma


subject: CHEBI:45863

object_name: Zollinger-Ellison syndrome


subject: CHEBI:45863

object_name: gastrinoma


subject: CHEBI:45863

object_name: pancreatic gastrinoma


subject: CHEBI:45863

object_name: insulinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Renal cell carcinoma recurrent


subject: CHEBI:31355

object_name: Renal cancer recurrent


subject: CHEBI:31355

object_name: Anal cancer stage IV


subject: CHEBI:31355

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Anal cancer recurrent


subject: CHEBI:31355

object_name: Stage IIIA Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIIA Anal Cancer AJCC v8


subject: CHEBI:31355

object_name: stage IIIA anal cancer


subject: CHEBI:31355

object_name: Stage IIIB Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: stage IIIB anal cancer


subject: CHEBI:31355

object_name: Stage IIIB Anal Cancer AJCC v8


subject: CHEBI:31355

object_name: stage III vaginal cancer


subject: CHEBI:31355

object_name: Stage III Vaginal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Vaginal cancer recurrent


subject: CHEBI:31355

object_name: stage IVA vaginal cancer


subject: CHEBI:31355

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Vaginal Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:31355

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:31355

object_name: Recurrent Rectal Cancer


subject: CHEBI:31355

object_name: Distal Urethral Carcinoma


subject: CHEBI:31355

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:31355

object_name: Rectal cancer stage IV


subject: CHEBI:31355

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:31355

object_name: posterior urethra cancer


subject: CHEBI:31355

object_name: Proximal Urethral Carcinoma


subject: CHEBI:31355

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:31355

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:31355

object_name: stage III cervical cancer


subject: CHEBI:31355

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Cervical carcinoma stage IVA


subject: CHEBI:31355

object_name: Cervical carcinoma stage IVB


subject: CHEBI:31355

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:31355

object_name: Recurrent Urethral Cancer


subject: CHEBI:31355

object_name: Cervix carcinoma recurrent


subject: CHEBI:31355

object_name: advanced adult primary liver cancer


subject: CHEBI:31355

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:31355

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:31355

object_name: stage IV esophageal cancer


subject: CHEBI:31355

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:31355

object_name: Stage III Esophageal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage III Esophageal Cancer


subject: CHEBI:31355

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:31355

object_name: urethral carcinoma associated with invasive bladder cancer


subject: CHEBI:31355

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:31355

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:31355

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:31355

object_name: Carcinoma of the prostate stage III


subject: CHEBI:31355

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:31355

object_name: Prostate cancer recurrent


subject: CHEBI:31355

object_name: Occult Lung Non-Small Cell Carcinoma


subject: CHEBI:31355

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:31355

object_name: male breast carcinoma